Invivyd expands COVID-19 study, develops measles antibody candidate

Go back to Invivyd expands COVID-19 study, develops measles antibody candidate
(NASDAQ: IVVD) Delayed: 0.77 -0.04 (4.94%)
Previous Close $0.81    52 Week High
Open $0.82    52 Week Low
Day High $0.88    P/E N/A 
Day Low $0.73    EPS
Volume 8,327,516